Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Prostate Enlargement/BPH Health Center

Font Size

FDA: Prostate Cancer Risk From BPH, Hair Loss Drugs

Proscar, Propecia, Avodart, Jalyn Increase Risk of High-Grade Prostate Cancer
WebMD Health News
Reviewed by Laura J. Martin, MD

June 9, 2011 -- The prostate drugs Proscar, Avodart, and Jalyn and the hair-loss drug Propecia add to the risk of high-grade prostate cancer, the FDA warns.

All of the drugs must change their labels to warn of the risk, which unexpectedly appeared in two different large-scale clinical trials.

Ironically, Proscar and Avodart appear to reduce the risk of low-grade prostate cancer, which is less aggressive than high-grade prostate cancer. But the increased risk of high-grade prostate cancer means the drugs can't claim to lower overall prostate cancer risk.

The FDA ruling follows the December 2010 vote of an FDA advisory panel, which rejected requests from Merck (for Proscar) and GlaxoSmithKline (for Avodart) to claim that the drugs prevent prostate cancer.

The male hair-loss drug Propecia has the same active ingredient as Proscar, although at one-fifth the dose. But the FDA says Propecia should carry the same prostate cancer warning as Proscar.

Even though the drugs are linked to prostate cancer, the risk is small. Men who are taking Proscar, Avodart, or Jalyn for benign prostatic hyperplasia (BPH) should not stop taking their medications, but should consult their doctors about their prostate cancer risk.

Proscar, Avodart, and Propecia are in the same class of drugs, known as 5-alpha-reductase inhibitors or 5-ARIs. Jalyn has the same active ingredient as Avodart, together with a drug called tamsulosin (Flomax). The FDA warning does not include Flomax, which is in a different class of prostate drugs called alpha blockers.

Other alpha blockers include Cardura, Hytrin, Uroxatral, and Rapaflo. Unlike the 5-ARI drugs, the alpha blockers are effective in treating the symptoms of BPH but have not been shown to reduce the risk of urinary retention due to an enlarged prostate.

Minoxidil is an alternative over-the-counter drug used to treat male pattern baldness.

Today on WebMD

Male Incontinence Slideshow
screening tests for men
What Is The Prostate
Foods To Boost Mens Heath
Enlarged Prostate BPH Complex Problem
Benign Prostatic Hyperplasia BPH Surgery
How Bad Are Urinary Symptoms From Benign Prostatic
Benign Prostatic Hyperplasia BPH Exams And Tests
Treating Enlarged Prostate
What Is The Prostate
Marks Prostate Enlarged
Low Testosterone Explained When Levels Are Too Low

WebMD Special Sections